Epidermal Growth Factor Receptor-Specific Nanoprobe Biodistribution in Mouse Models

Area of Science:

• Nanomedicine
• Biomaterials Science
• Immunology

Background:

• Nanoparticles are promising for targeted cancer therapy and imaging.
• Conventional nanoparticles often trigger immune responses, leading to accumulation in the liver and spleen.
• Developing immune-evasive nanoparticles is crucial for effective nanomedicine.

Purpose of the Study:

• To develop and evaluate gold and silver nanoparticles coated with biomolecules that evade immune detection.
• To assess the biodistribution and immune response of these novel nanoprobes in a mouse model.

Main Methods:

• Synthesis of 43 nm and 44 nm gold and silver nanoparticles.
• Coating nanoparticles with biomolecules: α-lipoic acid and mouse epidermal growth factor (mEGF).
• Biodistribution analysis using mass spectroscopy in mouse models 24 hours post-injection.

Main Results:

• mEGF-coated silver and gold nanoprobes exhibited background-level distribution across all organs, including the liver and spleen.
• Control nanoprobes showed significantly higher accumulation in the liver and spleen compared to mEGF-coated nanoprobes.
• Lack of sequestration suggests mEGF coating confers immune-evasive properties.

Conclusions:

• mEGF-coated gold and silver nanoprobes demonstrate reduced immune system recognition and sequestration.
• This biomimetic coating strategy shows potential for developing stealth nanocarriers for cancer applications.
• Further investigation into cytokine and interleukin levels is needed to confirm complete immune response avoidance.